MedPath

河北东圣科宇医药科技有限公司

Ownership
-
Established
2021-11-17
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Cobamamide Capsules

Product Name
腺苷钴胺胶囊
Approval Number
国药准字H20254021
Approval Date
Apr 30, 2025
NMPA

Fenofibrate Tablets(Ⅲ)

Product Name
非诺贝特片(Ⅲ)
Approval Number
国药准字H20253424
Approval Date
Feb 20, 2025
NMPA

Isosorbide Dinitrate Injection

Product Name
硝酸异山梨酯注射液
Approval Number
国药准字H20243646
Approval Date
Apr 30, 2024
NMPA

Piperacillin Sodium for Injection

Product Name
注射用哌拉西林钠
Approval Number
国药准字H20243397
Approval Date
Mar 29, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.